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ABSTRACT
DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING IN DIGNOSING GRAFT
DYSFUCNTION: A NON-INVASIVE ALTERNITAVE TO RENAL BIOPSIES

Elizabeth Marie Hollis
April 6, 2017
The thesis is divided into three parts. The first part focuses on background information
including how the kidney functions, diseases, and available kidney disease treatment
strategies. In addition, the thesis provides information on imaging instruments and how
they can be used to diagnose renal graft dysfunction. The second part focuses on
elucidating the parameters linked with highly accurate diagnosis of rejection. Four
parameters categories were tested: clinical biomarkers alone, individual mean apparent
diffusion coefficient (ADC) at 11-different b- values, mean ADCs of certain groups of bvalue, and fusion of clinical biomarkers and all b-values. The most accurate model was
found to be when the b-value of b=100 s/mm2 and b=700 s/mm2 were fused. The third part
of this thesis focuses on a study that uses Diffusion-Weighted MRI to diagnose and
differentiate two types of renal rejection. The system was found to correctly differentiate
the two types of rejection with a 98% accuracy. The last part of this thesis concludes the
work that has been done and states the possible trends and future avenues.
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CHAPTER I
TOWARDS NON-INVASIVE DIAGNOSTIC TECHNIQUES FOR EARLY
DETECTION OF ACUTE RENAL TRANSPLANT REJECTION: A REVIEW
A. Overview
The kidney is an essential yet complicated filtering organ of the body. When the
kidney reaches stage 5 chronic kidney disease, end stage renal failure, the preeminent
therapy is renal transplantation. Although renal transplants are the superior treatment, there
is a lack of kidney donors which has proven challenging. Therefore, all efforts should be
employed to prolong the survival rate of the transplanted kidney. However, renal graft
dysfunction (i.e., acute renal rejection) is one of the serious barriers to long term kidney
transplant survival. Currently, graft dysfunction’s gold standard of diagnosis is renal
biopsy. Although renal biopsy is helpful, it is not preferred due to its invasive nature, high
morbidity rates, and high economic cost. Therefore, noninvasive imaging techniques have
become the subject of extensive research and intense interest, giving strong promise to
replace, or at least to decrease, biopsy usage in diagnosing graft dysfunction. This survey
will discuss not only the current diagnosis and treatment of graft dysfunction but also the
state-of -the-art imaging techniques in detecting acute renal transplant rejection.
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B. Introduction
The kidney is a very important organ. It is the main filtration organ in the human
body, keeping the nutrients that the body needs in and expelling the waste that can become
toxic. Maintaining the health of this organ is very important. There are diseases that can
cause the kidney to decrease in function such as diabetes, hypertension, glomerular disease,
and polycystic kidney disease [1]. These can result in a gradual loss of kidney function
leading to waste build up in the body and cause the patient to develop chronic kidney
disease (CKD).
Chronic kidney disease affects about 26 million people with 17,000 transplants
being performed each year in the U.S. [2, 3]. Although transplants have greatly improved
the outcome of patients diagnosed with stage 5 CKD, complications can still arise. One of
the main concerns is graft dysfunction. Routine post-transplantation clinical evaluation of
kidney function is of immense importance to prevent the graft loss. The diagnostic
technique currently recommended by the National Kidney Foundation (NKF) to measure
overall kidney function is estimated Glomerular Filtration Rate (eGFR), which is based on
measuring the serum creatinine level. However, this test has low sensitivity and is a late
marker for renal graft dysfunction. Unfortunately, a significant change in serum creatinine
level is detectable only after the loss of 60% of renal function [4]. The needle biopsy is the
current gold standard for diagnosing different types of renal dysfunction. [4]. However,
needle biopsies are difficult to perform, costly, and time-consuming. More over renal
biopsy can lead to complications such as infections, bleeding, and, at times, death. With
Fthe evolution of computer aided diagnostic systems, we hope to diagnose different types
of graft dysfunction, saving time and money. Thus, there is a great need for new
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noninvasive techniques with the capability to provide accurate diagnosis of kidney
dysfunction is of countless clinical significance.
The main purpose of this chapter is to present an overview of current clinical
techniques for renal transplant function evaluation as well as an examination of new ways
to improve the detection of graft dysfunction using image-based technology.
The rest of this chapter is organized as follows. “Kidney Anatomy and Function,”
provides a brief overview of the treatment options for people who develop stage 5 CKD,
concentrating

on

transplantation

as

a

definitive

therapy.

“Renal

Problems/

Disease/Symptoms,” focuses on follow-up post transplantation care, which includes
possible complications that could arise with a concentration on graft dysfunction.
“Treatment,” concentrates on tests used to detect graft dysfunctions including the
traditional methods such as blood, urine, and renal biopsy. This is followed by the image
based techniques such as magnetic resonance imaging (MRI), and ultrasound.
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Figure 1. Coronal cross-section of a normal kidney with labeled anatomy.

C. Kidney Anatomy and Function
As stated before, kidneys are the main filtration system in the body. Kidneys are
able to keep needed nutrients like salts, sugar, and protein in. Conversely the kidney also
expels excess nutrients, water, and waste such as urea, and ammonia out of the body.
Kidneys help the body to maintain homeostasis as well by regulating blood pH, blood
pressure, and osmolality. Osmolality is the amount of particles of solutes that are
dissociated in a solvent [5]. Each kidney is shaped like a bean and is about the size of a
fist [6] and weighs about 150 g [7]. They are located in the lower back below the rib cage.
As shown in Figure 1, the kidney is composed of an outer “shell” (renal cortex), an inner
layer (renal medulla), and a hollow area where the urine is collected, (renal pelvis) [7] .
Inside the cortex and medulla are the filtration units known as the nephrons (see Figure. 2),
4

which are then made up of smaller subunits such as the glomerulus, vasa recta, and loop of
Henle [7]. Since the kidneys filter the blood it must be connected to veins and arteries. The
kidneys are connected to the renal artery and vein which is connected to the iliac artery and
vein, respectively. That is the general overview of the kidney anatomy, now this paper will
trace the filtration pathway of the blood. The blood enters the kidney by way of the renal
artery. Once there, the blood moves to the nephrons of the cortex where the blood then
enters the afferent arteriole which allows the blood to move through in the glomerulus. The
glomerulus is then able to filter out waste by leveraging blood pressure. Waste is filtered
into the Bowman’s capsule, to the lumen of the proximal tubule, then to the Loop of Henle
and thin segment, which can be found in the medulla. At these places in the nephron more
selective reabsorption can be done. From this, waste moves to the distal tubule and then
collecting tubule finally ends up in the renal pelvis. The waste that ends up in the renal
pelvis will then move out through the ureter to the bladder and then out of the body by way
of the urethra. The clean blood exits the glomerulus by way of the efferent arteriole. Once
blood reaches the efferent arteriole additional filtration takes place in the Peritubular
capillaries where the blood could also move down the Vasa recta in the medulla, nutrients
that were filtered out by the loop of Henle and thin segment can be reabsorbed there. The
blood then exits through the venules and then through the arcuate veins, finally leaves the
kidney through the renal vein. The clean blood then moves back to the heart [7]. As one
can see this organ is very complex and with this complexity many problems can arise. In
the next section this article will discuss what can go wrong as well risk associated with
increased changes of developing these complications.
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Figure 2. A nephron structure with labeled anatomy and pathway of filtration.
D. Renal Problems/ Disease/ Symptoms
The renal system is a very complex system, in which various complications and
diseases can arise. There are multiple conditions and/or diseases that can arise in the kidney
such as kidney stones, injury, infections, and cancer. The focus of this chapter will be on
CKD, the 9th leading cause of death in America [8]. CKD is a gradual loss of function of
the kidney, where the nephrons become compromised [2]. To date, 26 million people in
the U.S. are living with CKD [2]. The risk of developing CKD could be increased due to a
few different factors such as; pre-existing conditions, diseases, age, race, lifestyles and
family history. Conditions that increase the likelihood of developing CKD include diabetes,
high blood pressure, heart disease, and high cholesterol [9]. People with the following
diseases are at increased risk of CKD, they include; Human Immunodeficiency Virus
6

(HIV), Hepatitis C, Metabolic syndrome, cancer, and sickle cell trait [10]. When an
individual is 65 years or older they are more at risk. African Americans tend to also have
a greater risk compared to the rest of the population [9] Lifestyles that increase risk include
people that are obese [11] or people that smoke [9] or exposed to second hand smoke. In
terms of family history of CKD, that if a patient has a parent or family member with CKD
they have a greater chance of developing CKD [9].
People with the aforementioned risk factors should inform their doctors if they
experience CKD-related symptoms, summarized below become present. In early stage
CKD the patient may be asymptomatic but as the disease progresses symptoms may arise.
Symptoms can include change in urination whether it changes in frequency, feeling, color,
or texture. The urine can also start to contain blood [12]. Apart from the change in urination
symptoms such as limb swelling, iron build up that can cause nose bleeds and bad breath
[12]. As the disease progresses infection like symptoms can arise [13]. CKD can also have
an effect not only on the body but also on mental state and activity level. These symptoms
can include fatigue, generalized weakness, decreased libido, change in memory [13], and
compromised mental function [12]. Other rare yet, more serious, symptoms include rash,
generalized pain, chest pain, and shortness of breath [12-15]. Patients with any of these last
symptoms should seek immediate medical attention. Every patient is different and there is
no set relationship between symptoms and stage of kidney disease [13]. If left untreated
symptoms should worsen and lead to stage 5 CKD/ kidney failure. If the patient remains
untreated in stage 5 CKD, toxins will build up in the body and cause death. To prevent this
from happening the patient should be treated with dialysis or transplantation. The next
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section will inspect treatment options for patients at stage 5 CKD, concentrating mostly on
transplantation.
E. Treatment
Luckily, treatments for patients with stage 5 renal failure include blood dialysis or
renal transplantation. Blood dialysis is when one's blood is filtered of waste or excess
water, either with use of a machine outside the body (hemodialysis) or chemically inside
the body (peritoneal dialysis) [16]. Although dialysis is a helpful treatment, kidney
transplantation constitutes a longer term treatment Kidney translation involves the surgical
insertion of a donor's kidney into the CKD patient. The new kidney should improve
filtration for the patient. Since transplantation is the definitive therapy for End-Stage Renal
Disease (ESRD), the following describes in more details the kidney transplantation
procedure and associated complications and diseases.
1. Transplantation
Renal transplantation does not mean nephrectomy (i.e. removal of the
malfunctioned kidney) is performed on the patient with CKD. The CKD patient usually
keeps both of the kidneys, unless those kidneys are causing pain or other complications
[17]. This means the patient will have three kidneys after the procedure. The donated
kidney also has its own ureter, renal artery, and vein intact. The donated kidney is placed
distal (below) the native kidneys with the donated ureter connecting to the bladder, and the
renal artery and vein connecting to the iliac artery and vein of the patient, respectively [18].
Figure 3 demonstrates the entire anatomy of a patient’s renal system after transplantation.
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Figure 3. Anatomy of renal system of a patient after kidney transplant.
This procedure seems fairly simple in concept. However, the process to find that
donor can be fairly complicated medically, logistically, and legally. There are two different
types of renal transplantation donors namely cadaver and living donors. Only one-third of
the transplantations are from living donors; whereas the remaining two-thirds are from
cadaver donors [19]. The type of donor is often the first decision the physician and the
CKD patient must make. Often a more desirable choice would be to have a living donor
give one of their kidneys. However, this is not without its complications. The donor must
meet all criteria such as being HLA (+ or -) and/or ABO compatible, in good physical
health, and in no way coerced against their will to donate [19, 20]. This means the donors
can back out at any time. Therefore, even if there is a willing live donor the physician may
persuade the patient to get on the United Network of Organ Sharing (UNOS) [21]. Based
on where the patient is on the list determines if and when they will receive a donated
kidney. The donated kidneys from this list are from cadaver donors. In order for the
9

cadaver’s kidney to be viable the kidney must be functioning before death and undamaged.
Also, the time and location of death may play a part since the kidney must not decompose
before the kidney can be donated [19]. In the U.S., the living donors must be willing to
donate their kidney and cadaver donors must also make it clear that they are willing to be
a donor after death.
With all of these criteria, it is clear why there are still over 100,800 people wating
for a kidney, despite 17,000 kidney transplants are performed annually in the United States.
With this in mind, it is very important that the transplanted kidney is kept viable as long as
possible to avoid nephrectomy and repeat transplantation [3]. In the following section, we
shall overview what happens during post-transplantation care, which should improve the
organ viability following surgery. This includes follow up procedures and the
complications that arise for transplant patients.
F. Post-Transplant Follow-Ups and Complications
Just as with any medical procedure, complications can arise, such as infection and
bleeding so one must remain under the constant care of one’s physician. They must
continue follow ups to ensure that the new kidney is functioning and that new
complications do not arise. To prevent new complications from arising, the patient should
follow the instructions of their physician by taking their anti-rejection medications and
visiting their physician as directed [22]. The frequency at which a patient has to visit their
physician will decrease as time after transplantation increases. Once the patient has reached
210 days post-operatively, they should be seeing their physician monthly or if
abnormalities arise [23]. During those clinical visits, various tests such as examining the
patient’s weight, blood pressure, and temperature will be done to assess both the overall
10

health of the patient and the health of the kidney. The urine and blood lab test will be
discussed later in this article. If these tests appear abnormal, the physician may order a
renal biopsy and/or scans [24]; both will be discussed in greater detail later in the article.
For now, this article will concentrate on the complications that can arise during these tests,
specifically those complications that are associated with renal transplants. This section will
take a look at those types and concentrate specifically on graft dysfunction. First, this
article will explain different types of complications other than graft dysfunction.
1. Types of Complications
There are six categories of complications including: urological complications,
vascular complications, fluid collection, recurrent native renal disease, graft dysfunction,
and neoplasms. This section will take a short look at the first five complications, then the
next section will go a little more in depth for graft dysfunctions. Urological complications
are simply when organs involved in the urinary system (e.g, bladder, urethra and ureter)
become obstructed or permit urine leakage [25, 26]. Vascular complications involving the
renal or iliac artery/vein may include narrowing, blockage or formations of holes in the
vascular system [27]. Fluid collection is closely related to urological and/or vascular
complication in which blood or urine will collect in unwanted areas. This residual
collection of blood or urine may result in urinomas, hematomas, abscesses, or lymphoceles
[26-28]. Neoplasms are abnormal growth such as tumors that grow on the renal system and
other areas. This is said to be caused by the prolonged exposure to immune suppressing
drugs [27, 29, 30]. Lastly, recurrent native renal disease is when the disease that caused the
patient to develop CKD, such as diabetes, is now affecting the donated kidney [31, 32].
Unfortunately, patients may develop a combination of the previously mentioned health
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complications. It is critical to diagnose and treat these complications, as soon as possible.
Most of these complications are typically easier to detect when compared to graft
dysfunction. This is because these complications can be detected using various imaging
techniques such as ultrasounds and MRIs [33]. These imaging techniques will be discussed
later

in the paper, but the concentration will be more on graft dysfunction. The

complication and cause that is more challenging to diagnose is graft dysfunction, which
shall be examined next.
2. Graft Dysfunctions
Graft dysfunction is defined as a newly transplanted organ that longer functions.
As a consequence, toxins build up, and the body rejects the transplanted organ [27]. It was
calculated that within the first 5 years post transplantation, 15% of patients will experience
graft dysfunction [34]. There are three classes of graft dysfunction: hyperacute, acute, and
chronic. The type of graft dysfunction is differentiated by the mechanism and in part time
of dysfunction onset [35]. Currently, hyperacute rejection is relatively rare nowadays. This
class of rejection is caused by antibodies attacking the donated organ due to the donated
organ having the wrong HLA (+ or -) and/or ABO blood antigens. Hyperacute rejection
generally presents itself within in minutes or hours after transplantation [20]. There is no
cure for hyperacute rejection [36]. Chronic kidney rejection’s mechanism is not well
understood but appears to present itself after 5 years post-transplant [20]. This article will
concentrate on acute kidney rejection (AKR). Just as there are different types of
complications in renal transplant, there are different causes of graft dysfunction. This can
provide somewhat of a challenge in diagnosis and treatment. This is due to the fact that
there is a different treatment for each cause of graft dysfunction. There are four different
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causes of graft dysfunction; they include: acute tubular necrosis antibody-mediated
rejection (ATN), T-cell mediated rejection, immunosuppressive toxicity (IT), and viral
infection (VI). ATN is when the antibodies of the patient recognize and elicit an immuneresponse against the newly donated kidney as a foreign body, which ultimately causes the
tissue to become necrotic and die. ATN is treated with a drug therapy regimen that may
include plasmapheresis, mycophenolate mofetil, and tacrolimus [37-39]. T-cell mediated
rejection is when killer T-cells attack the donated organ causing apoptosis in the tissue
[40]. T-cell mediated rejection may be treated with corticosteroids, antithymocyte globulin,
and immunosuppression therapy. Patients who experience antibody-mediated rejection
may not respond to the T-cell mediated rejection treatment [41-43]. Immunosuppressive
toxicity arise when immunosuppressive drugs (e.g., cyclosporine and tacrolimus), used to
prevent kidney transplantation rejection, actually causes renal failure due to the
nephrotoxic nature Nephrotoxicity may be treated by stopping, changing, or altering the
does or type of drug. [44-46]. Another cause of graft dysfunction includes VI which is
caused by Cytomegalovirus or Herpes simplex virus entering the body and damage the
kidney [47]. Patients with these viral injections may receive immunosuppressant and/or
antiviral treatments [37].

The causes of AKR can be presented singularly or in

combination, which can add to the difficulty in diagnosing the cause of AKR. How the
cause of these graft dysfunctions isdiagnosed will be discussed in the next section of this
chapter.
G. Detection/Assessment of Renal Rejection
It is important the patient keeps regular visits with their physician to ensure their
newly transplanted organ functions properly. The main focus of the post-transplantation
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follow-up is to keep the graft viable for as long as possible. If the patient continues regular
follow-ups and notifies the physician of any symptoms that arise, it is feasible to detect
complications early and save the donated organ. This section will give an overview of the
existing techniques/methods for diagnosing graft dysfunction, including traditional nonimaged-based and new techniques underdevelopment, as detailed below
1. Traditional Methods
Traditionally, blood and urine analysis are implemented during a routine followup. Abnormal blood or urine test may prompt the physician to order a renal biopsy for a
definitive diagnosis. This diagnosis should also tell the physician what is causing the
kidney malfunction. These next sections will show how these diagnoses are determined.
First, this article will discuss urine testing.
a. Urine Tests
A simple and non-invasive urine assessment can test for multiple substances. Based
on the patient’s urine, the physician measures a number of biomarkers to determine eGFR.
Most often the biomarker used to calculate eGFR is serum creatinine. To calculate eGFR,
the concentration of creatinine found in the urine sample is placed into an equation which
has constants that change based on sex, race, and age. Using the calculated eGFR, one may
determine what stage of function the kidney(s) are in, 0 being at an increased risk and 5
being end stage renal failure [48, 49]. This diagnostic technique is presently suggested by
the National Kidney Foundation (NKF) to measure overall kidney function [4]. However,
this test has low sensitivity and is a late stage marker of renal dysfunction (a significant
change in serum creatinine level is detectable only after the loss of 60% of renal function),
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and it does not assess the function of individual kidneys [4]. The next test that shall be
discussed will be a blood test.
b. Blood Test/Works
This method is similar to urine analysis in that it measures estimated eGFR using
serum creatinine. However, since it does pierce the skin when obtaining the blood, this test
is slightly more invasive than urine analysis. A complete blood count and differential count
(CBC and diff) [50] measures more substances than urine samples, including detecting the
presence of burred blood cells which can be present in patients with CKD. Burr cells are
blood cells that appear almost gear like. They appear when there is an excess amount of
waste in the body, which is likely to happen in patients with CKD [51, 52]. Although blood
analysis has a few more benefits than a urine test, it has the similar setback in that the test
has low sensitivity and is a late marker of renal dysfunction and it does not assess the
function of individual kidneys [4]. The last traditional method that shall be discussed is a
renal biopsy.
c. Biopsy (“Gold Standard”)
Renal biopsy is the gold standard for the graft function assessment; however, it is
by far the most invasive. For this procedure, a renal biopsy needle is guided by a camera,
ultrasound or x-ray and is inserted into the patient’s back and kidney, as shown in Figure
4 [50]. The tissue obtained is evaluated under a microscope [53]. The patient is fully
conscious and told not to move [50]. If the patient moves, they run the risk of perching
other organs, excessive bleeding and infections. Patients who use blood thinners
particularly have and increased risk for excessive bleeding. Biopsy-associated infection
may in part be related to the fact the patients are on an immunosuppressive therapy regimen
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to prevent renal transplantation rejection [34, 54]. These complications can lead to
nephrectomy or even death; both occur in 1 in every 1,000 renal biopsies [34].

Figure 4. Example of renal biopsy procedure guided with Ultrasound.
Along with the invasiveness of the procedure, there are multiple setbacks that are
associated with this procedure. Renal biopsies, although a useful tool, have the tendency
to give a missed diagnosis or inaccurately estimate the extent of the problem. This is
because it is only sampling a small portion of the kidney. So if the needle is even slightly
off target, the biopsy needle can miss an effective portion of the kidney, resulting in a false
negative. As a consequence, the patient may have to undergo another biopsy, which may
cause the patient additional pain and precious time lost to save the graft. On the subject of
time, it takes up to two weeks to obtain renal biopsy results [55]. That time that could be
used for treatment is wasted and can result in failure of the donated kidney. On top of these
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setbacks, the financial cost of the procedure can reach over $20,000 [56]. In essence, renal
failure can cause both physical pain and a financial burden.
Though these tests have been routinely used for transplant assessment and have
helped in improving graft survival, new methods are needed to diagnose and differentiate
the cause of graft dysfunction. Additionally, existing techniques, i.e. eGFR and biopsy, for
diagnosis of renal rejection are late biomarkers. Moreover, renal biopsy has significant
morbidity, is very expensive, takes up to two weeks to get the final report, and can result
in over- or under-estimates of problems by only sampling small areas of the kidney.
Therefore, the development of non-invasive tests to monitor kidney transplant rejection
will permit early intervention prevent rejection and associated damages, which will
improve long-term outcomes.
The following section will overview existing non-invasive imaging techniques and
their possible use for renal function assessments and graft dysfunction diagnoses. The
imaging techniques that are included in this article are ultrasound and MRI.
2. Image-Based Techniques for Renal Transplant Evaluation
The progress of computer-aided diagnosis (CAD) systems for renal transplant
assessment using diverse imaging modalities is a current area of amplified research. Noninvasive imaging-based techniques have been clinically used to assess transplanted kidneys
with the advantage of providing information on each kidney separately. For example,
radionuclide imaging (also termed scintigraphy), the traditional technique in renal imaging,
is an admirable modality for gauging graft function, both qualitatively and quantitatively,
while also assessing for common complications [57]. However, this procedure appears to
miss the mark in presenting accurate anatomical information due to its narrow spatial
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resolution. Therefore, functional idiosyncrasies inside different areas of the kidney (such
as cortex and medulla) cannot be differentiated precisely [58]. Additionally, radionuclide
imaging contains radiation exposure [59], thus restraining the range of its applications,
particularly in monitoring diseases such as Acute Tubular Necrosis or cyclosporine [60].
Computed tomography (CT) is a commonly accessible equipment that uses contrast agents
that permits accurate evaluation of numerous diseases and complications in renal
transplantation and at a lower cost than magnetic resonance imaging (MRI) [61].
Conversely, data gathered by CT to sense renal acute rejection lacks specificity and the
contrast agents used are currently nephrotoxic. Therefore, currently CT scans are typically
restricted to the detection of acute renal rejection [62]. In contrast to these radionuclides
and CTs, ultrasound (US) and magnetic resonance imaging (MRI) are the most popular
imaging modalities used for the diagnosis of kidney diseases, as described in the upcoming
sections.
a. Ultrasound (US) Imaging
Typically, ultrasound (US) imaging is used for the assessment of renal allografts
functionality during the early phases of postoperative period as well long-term follow-up.
This imaging modality is preferred over some of the others because it is easy to perform
and repeat, inexpensive, and repeated, inexpensive, and is non-toxic to the kidneys[63].
Pulsatility index (PI) and resistance index (RI) are the most common measurements to
assess renal functionality using US. Below, we will discuss some recent studies that
assessed renal transplants using different forms of ultrasound (e.g., power Doppler (PD),
color Doppler (CD), contrast enhanced (CE), etc.) as shown in Figure 5.
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Figure 5. Example of different Ultrasounds.
In an investigation to illustrate the factors that impact Pulsatility index and
resistance index in patients with immediate (IGF), slow (SGF), or delayed (DGF) kidney
graft function, Chudek et al. [64] observed that ischemic injury, which occurred chiefly
prior to organ harvesting, played an overriding role in defining intra-renal resistance in the
early post-transplant period. Saracino et al. [65] investigated whether the long-term renal
functionality could be predicted using resistance index measurements obtained soon after
renal transplantation. On the other hand, Kramann et al. [66] evaluated whether resistance
index measurements could to predict renal allograft survival. They concluded long-term
allograft survival predictions would require attainment of, resistance index measurements
12-18 month post-transplantation. Krejvci et al. [67] utilized a CD imaging, PD imaging,
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and composite gray-scale to examine the power of US for early detection of a subclinical
acute rejection. A significant difference between the different groups mentioned before in
their study was found. In another study by Damasio et al. [68], the ability of Doppler US
to differentiate between dual and single kidney transplantation (DKT and SKT,
respectively) was exploited. After the measurement of resistance index parameters for both
dual kidney transplantation and single kidney transplantation groups, they concluded that
those patients with dual kidney transplantation had lower kidney volumes and higher
resistance index than those with single kidney transplantation.
A study by Shebel et al. [69] investigated the ability of PD in the differentiation
between acute tubular necrosis and acute rejection (AR). Their study included 67 renal
transplant recipients in the early post-transplantation period. After a manual placement of
region of interests, cortical perfusion (CP) and resistance index were measured for all
recipients and CP was tested with respect to resistance index and serum creatinine (SCr).
Upon their own CP grading scale system, they found a statistical significant relationship
between their SCr and CP grading (P < 0.01) and between resistance index and CP grading
(P < 0.05). They concluded that the power Doppler using cortical perfusion grading is more
sensitive in the detection of early AR compared to resistance index and cross-sectional
measurements.
Fischer et al. [70] demonstrated ultrasound contrast media (USCM) was more
effective than ultrasound imaging that uses the resistance index indicator in the diagnosis
of early stage allograft dysfunction. Additionally, Benozzi et al. [71] discovered that both
contrast enhanced US and US could identify grafts with early stage dysfunction, but only
some contrast enhanced US derived parameters could discriminate between AR and ATN.
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Schwenger et al. [72] exploited the power of CE sonography (CES) in early prediction of
long-term renal transplant functionality compared to color doppler ultrasonography
(CDUS). In their study, 68 renal transplants were investigated using both CES and CDUS
one week after transplantation. Renal blood flow (RBF) and resistance index were
measured for all transplant recipients. These measurements were evaluated in relation to
the recipients’ clinical data represented by glomerular filtration rate (GFR) in a posttransplantation period, ranging from one week to one year. Based on their data they
concluded RBF measurements using CES was significantly corresponded with kidney
functionality in the aforementioned period after transplantation period. However,
resistance index measurements using CDUS did not track with kidney functionality. In
another study Gocze et al. [73] differentiated between acute kidney injury (AKI) stages
using contrast enhanced US based on the quantification of blood perfusion. Instead of
generating time-intensity curves (TIC), they used another quantification method called
arrival time parametric imaging (ATPI). Their study included 10 patients who underwent
contrast enhanced US of which 4 patients had no evidence of AKI, 1 with stage 1 AKI, and
5 with stage 2 or 3 AKI. Color-maps based on inflow time (IT) of the contrast agent were
generated using the contrast enhanced US-ATPI quantification method and were divided
into six major categories based on their values. Then, these ITs were assessed for different
poles of kidney cortex (i.e. lower, middle, and upper) and the total IT was the sum of all
arrival times of these three poles for each kidney. They observed that patients with stage 2
or 3 AKI have more delayed ITs than those of the other groups. They concluded that
contrast enhanced US-ATPI technique may help in detecting different stages of AKI.
Recently, Jin et al. [74] assessed renal allografts using contrast enhanced US. In their study,
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57 renal transplant patients underwent contrast enhanced US. Then, they were divided into
three groups: 23 patients with AR (group 1), 10 patients with ATN (group 2), and 24
patients with normal allografts (group 3). After a manual placement of region of interests,
a new index to detect AR called rising time (RT) was measured instead of arrival time
(AT). In addition, time to peak (TTP) and delta time among region of interests (∆RT and
∆TTP) were measured, analyzed, and correlated with clinical data (e.g., GFR). They found
that RT, TIP, and (∆RT and ∆TTP) were significantly higher in group 1 compared to those
in group 2 and group 3.
Although several studies utilized US to evaluate and assess renal functionality preand post-transplantation by evaluating conventional ultrasound parameters, for instance the
Pulsatility index and RI, two contradictory studies [75, 76] concluded that resistance index
is not an exact sign of renal graft dysfunction, and it could only offer a predictive marker
of the graft. Moreover, Doppler US may give high resistance index and Pulsatility index
values (>0.8), which is an indication comparable to those of ATN [66, 77]. These
contradictions led researchers and investigators to examine a different imaging modality to
assess renal functionality (e.g., MRI). In the next section, we will discuss up-to-date studies
utilizing different MR imaging modalities.
b. Magnetic Resonance Imaging (MRI)
MR imaging is a non-ionizing technique that has become the most important noninvasive diagnostic tool in many clinical applications [78]. MRI not only provides excellent
morphological information but also possesses the ability to offer the best soft tissue contrast
compared to all imaging techniques (e.g., US and CT), which allows advanced analysis of
different aspects of renal function. There are various specific types of MRI scans. While
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some of these types provide only structural but not functional information, other MRI
modalities, such as dynamic MRI, BOLD MRI and diffusion MRI are frequently used for
renal function evaluation. Next, we overview the recent studies utilizing these MRI
modalities for renal transplant assessment.
i.

Dynamic Contrast-Enhanced (DCE) MRI

Renal dynamic MRI is an emerging imaging technique for assessing kidney
function. The technique is based on repeated imaging of the organ-of-interest before and
after administration of a contrast-gent. Figure 6 shows a typical example of DCE-MRI of
the kidney. In recent years, several studies have exploited DCE-MRI to non-invasively
analyze kidney function in both native and transplanted kidneys. This imaging modality
has the ability to non-invasively characterize important functional parameters (e.g., RBF,
GFR, and renal plasma flow (RPF)) as well as tissue-specific functional changes.

Figure 6. Example of an DCE-MRI sequence with Pre -, Post-, and Late- contrast images
In particular, a study by de Priester et al. [79] utilized dynamic MR enhancement
curves to qualitatively evaluate diseased (27 patients) and non-diseased (8 patients) renal
transplants. Cortical and the medullary enhancement parameters were obtained from a
physiological model that was fitted to the raw data. Cortical arterial blood volume and
medullary wash-out rates were found as the main discriminatory parameters between
diseased and non-diseased patients. Yuksel [80] introduced a DCE-MRI-based CAD
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system for the evaluation of transplant function, which employed deformable image
segmentation, kidney registration, and cortical perfusion construction. After kidney
segmentation, a manual cortical region of interest is used to construct the perfusion curve
from the co-aligned images and the kidney function is evaluated visually based on the
pattern of the constructed curves. Several studies [81-84] have been developed for early
diagnosis of acute transplant rejection and included automated kidney segmentation, local
kidney alignment, and classification of the allograft status. Empirical (nonparametric)
cortical parameters were employed for the evaluation of kidney status using: the peak
signal intensity, the time-to-peak, the wash-in slope (slope between the peak and the first
minimum), and the wash-out slope (peak and the signal measured from the last image in
the sequence). A supervised Bayesian classifier was employed and the system classified
13 out 15 and 15 out of 15 correctly for both training and testing, respectively. Similar
approaches were proposed in [85-87]. The studies utilized a global alignment step of the
MR images, the whole kidney perfusion curves were analyzed rather than the cortical one
as in [81-84], and the systems were evaluated on a 100 patient cohort and achieved a 94%
diagnostic accuracy using Bayesian supervised classifier. Functional evaluation of cortical
and medullary regions by Rusinek et al. [88] exploited rigid alignment, graph-cut
segmentation, and compartmental modeling. Their framework was tested on 22 clinical
data sets and the study concluded that the accuracy and precision in RPF and GFR are
acceptable for clinical use.
A semi-automated framework was proposed by Zikic et al. [89] to evaluate kidney
kinetic parameters. Their framework employed manually segmenting the kidney and
applying motion correction steps using template-matching based registration to correct for

24

image motion. Functional parameters (plasma volume and tubular flow) evaluation,
however; was performed visually by trained physicians for 10 data sets of healthy
volunteers. De Senneville [90] conducted a similar study to evaluate renal function for
healthy volunteers and transplant patients. Their framework performs sequentially rigidbody registration, manual cortex segmentation, and the GFR estimation using PatlakRutland model. Compared to the transplanted kidneys, a significant uncertainty reduction
on the computed GFR for native kidneys was observed. Aslan et al. [91] developed an
automated CAD system to classify normal kidney function from kidney rejection using
DCE-MRI. Following kidney segmentation, three classification methods (least square
support vector machines (LS-SVM), Mahalanobis distance, and the Euclidean distance)
were compared to assess transplant status based on medullary perfusion curves. On a cohort
of 55 clinical data sets, they achieved a diagnostic accuracy, sensitivity, and specificity of
84%, 75%, and 96%, respectively using the Mahalanobis distance-based classifier. A trace
kinetic modeling-based framework was proposed by Anderlik et al. [92] for quantitative
assessment of kidney function. The GFR was estimated from the time-intensity curves for
11 data sets after motion correction using Sourbron et al. [93] compartment model. A
framework by Zollner et al. [94] employed a k-means clustering [95] method to extracted
regional functional kidney parameters. Only four dynamic MRI data sets were used and
qualitative evaluation of the mean signal intensity time courses of kidney regions was
performed. Wentland et al. [96] utilized MRI-based intrarenal perfusion measurement to
differentiate between normal-functioning kidney allografts and allografts with ATN or
acute rejection (AR) on a cohort of 24 biopsy proven patients. The study concluded that
the cortical and medullary blood flow is significantly reduced in grafts experiencing AR,
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as compared with normal grafts. Additionally, AR patients demonstrated medullary blood
flow reduction as compared with ATN patients.
Recently, a study by Abou El-Ghar et al. [97] explored the feasibility of DCEMRI
in evaluation of renal allograft dysfunction. Their CAD system employed computer based
techniques for motion correction and creation of renographic curves. Functional evaluation
on 55 patients using the mean medullary intensity achieved sensitivity, specificity and
accuracy of 75%, 96% and 84%, respectively, to separate normal kidneys from impaired
ones. Yamamoto et al. [98] utilized dynamic MRI to prospectively assess its ability to
identify the cause of acute graft dysfunction. Their study employed 60 patients, 31 of which
had normal function and 29 had acute dysfunction due to AR. Their study employed a
multicompartmental tracer kinetic model to estimate the GFR and mean transit time (MTT)
at different compartments of the kidney. The study documented differences in the fractional
MTT values between normal grafts and grafts undergoing AR or ATN; however,
substantial overlaps among these groups and with normal kidneys were observed.
Hodneland et al. [99] developed a framework for the estimation of kidney indexes. Their
approach combined viscous fluid model for motion correction of the kidney and semiautomated kidney segmentation with the nearest neighbor approach. Two healthy
volunteers were enrolled in the study with a total of four data sets for evaluation. The study
reported a slight underestimation of GFR values compared with the creatinine reference
values. A study by Positano et al. [100] included a two-step rigid registration and adaptive
prediction of kidney position for the estimation for renal parameters. Perfusion curves were
constructed for both automatically and manually registered data sets. Then, four functional
indices (peak signal intensity, MTT, initial up-slope, and time to peak) were extracted. The

26

study concluded that for both curves the perfusion parameters were similar. A framework
by Khalifa et al. [101, 102] was proposed for automated classification of kidney transplant
status. The system included kidney segmentation and the local kidney motion correction
using by a Laplace partial differential equation-based method [103, 104]. Their initial study
[101] included only 26 data sets, a K-nearest neighbor classifier, and two empirical
parameters (the time-to-peak and wash-out slope) for evaluation. Their system achieved a
92.31% correct classification using the whole kidney perfusion curves. Their framework
was extended in [102] by using four augmented cortical empirical parameters (peak
intensity value, time-to-peak, up-slope and average plateau) by the genetic algorithm [105].
Unlike [101], the system was tested on 50 patients, and the overall diagnostic accuracy
increased to 96%. Another study [95] extended the work in [101, 102] and employed the
gamma-variate analytical function-based model to fit agent cortical kinetic curves. Both
functional model parameters and the time-to-peak and average plateau were used to assess
the transplant status in a cohort of 50 patients.
Although DCE-MRI has been employed as a widespread imaging technique to
develop several CAD systems for renal transplants assessment purpose, the contrast agents
may implicate nephrogenic systemic fibrosis; thus, many medical centers are reluctant in
applying the DCE-MRI to patients with renal disease [99]. In order to circumvent this
major drawback, DW-MRI and BOLD-MRI have been recently exploited to assess renal
transplants as they do not involve any use of contrast agents, like DCE-MRI. Below, we
will briefly discuss some recent renal transplant assessment studies using BOLD-MRI.
This is followed by a short discussion on other studies that utilized DW-MRI to assess
renal transplants.
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ii.

Blood Oxygen Level Dependent (BOLD) MRI

In addition to DCE-MRI, another imaging technique, called BOLD-MRI, has been
utilized to study renal rejection using the amount of oxygen diffused blood (i.e. oxygen
bioavailability) in the kidney determine if it is functioning properly. Specifically, the
amount of deoxyhemoglobin is measured by the apparent relaxation rate (R2*) parameter
[107].

Figure 7. BOLD-MRI grey scale images (a) normal kidney and (b) kidney with graft
dysfunction and R2* color-maps images (c) normal kidney and (d) kidney with graft
dysfunction.
In particular, Djamali et al. [108] investigated the ability of BOLD-MRI to assess
renal allografts. In their study, 23 patients underwent BOLD-MRI scans, of which 5 were
normal allografts and 18 had acute allograft dysfunction (5 with ATN and 13 with AR).
Medullary and cortical region of interests were placed, and mean cortical (CR2*),
medullary (MR2*), and medullary to cortical (MCR2*) were calculated. They found that
MR2* and MCR2* values of patients with ATN and AR were significantly decreased more
than those with normal allografts. However, no differences in CR2* values between the
different groups were observed. In a similar study by Han et al. [109], BOLD-MRI was
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conducted to differentiate between patients with AR and ATN after transplantation. Their
study included 110 patients; 82 with normal allografts (group 1) and 28 with kidney
dysfunction, including 21 with AR (group 2) and 7 with ATN (group 3). Group 2 was
divided into two subgroups: 13 patients with T-cell-mediated rejection (TMR) and 8
patients with antibody-mediated rejection (AMR). Manual region of interests were placed
in the cortical and medullary regions, and CR2*, MR2*, and MCR2* were compared
between different groups. They performed a statistical analysis, and they found that values
of CR2*, MR2*, and MCR2* of group 2 were reduced compared to those of the other two
groups. Contradictory to Djamali et al. [108] study, they found that values of MR2* of
group 3 were higher than those of group 1. However, no significant difference was
observed between the TMR and AMR subgroups.
Sadowski et al. [110] employed BOLD-MRI to assess kidney transplants. Manual
cortical and medullary region of interests were placed on 17 patients who underwent
BOLD-MRI scans, and these patients were divided into three groups: 5 patients with
normal allografts (group 1), 4 with ATN (group 2), and 8 with AR (group 3). The MR2*
and CR2* were calculated in the same way as their previous study [108], and compared
between the different groups. Specifically, MR2* values of group 3 allografts were
decreased compared to those of group 1 and group 2, while no significant difference was
observed in MR2* values between group 1 and group 2. However, no difference was
detected in CR2* values among the three groups. Another interesting study by Liu et
al.[107] was investigated to detect renal allograft rejection using BOLD-MRI. A total
number of 50 patients with renal allografts were included and divided into three groups as
35 patients with normal allografts (group 1), 10 patients with AR (group 2), and 5 patients
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with ATN (group 3). After cortical and medullary region of interests placement, CR2* and
MR2* were measured to assess the three groups. Group 2 had the lowest MR2*, while no
significant difference was detected in CR2* values among the three groups.
Although BOLD-MRI is a valuable imaging technique that has been investigated
by some researchers in detecting renal allografts dysfunction, BOLD-MRI remains
challenging, not only because of the low of signal-to-noise ratio (SNR) and the weakness
of the electromagnetic fields [111], but also the limited applicability of renal BOLD-MRI
due to kidney motions and susceptibility induced by bowel gas which may lead to impaired
image quality [112].
iii.

Diffusion-Weighted (DW) MRI:

Recently, DW-MRI has become a subject of extensive research as an emerging
imaging modality for renal function assessment thanks to DW-MRI’s ability to provide
both anatomical and functional information, while avoiding radiation exposures (like CT)
and contras agents’ administration (like DCE-MRI). For DW-MRI, its functional
parameter, called apparent diffusion coefficient (ADC), is estimated from different
gradient field strengths and duration (b-values), as shown in Figure 8, to describe the
unique tissue characteristics of inner spatial water behavior [112]. Therefore, several
studies have utilized DW-MRI to assess renal functionality by measuring the ADC values,
but the results have varied [107].

30

Figure 8. Example of an DW-MRI sequence at different b-values.
A study by Eisenberger et al. [113] was conducted to assess renal allografts
functionality. They started with a manual placement of region of interests in the upper,
middle, and lower poles of the cortex and medulla on several slices to cover large regions
of the allograft. Then, they calculated the means and standard deviations of the ADCs from
all b-values, which combines both the perfusion free ADC and microcirculation
parameters, quantified with perfusion fraction, Fp. A significant reduction in these
parameters was observed in the cortex and the medulla for the AR and ATN patients, and
the aforementioned parameters were correlated with the creatinine clearance (CrCl) values.
Similarly, a recent study by Hueper et al. [114] included 64 patients with renal allografts,
of which 33 were patients with initial graft function (IGF) and 31 were patients with DGF.
These patients underwent DW-MRI scans at two b-values (0 and 600 s/mm2). After
placement of manual region of interests and estimation of renal diffusion parameters,
including ADC and Fp, they concluded that renal diffusion parameters were significantly
reduced in patients with DGF and their values well correlated with renal function and renal
allograft fibrosis in biopsy specimens. Xu et al. [115] investigated the power of DW-MRI
to diagnose AR renal allografts on 26 biopsy-proven rejection and 43 non-rejection
patients. Higher ADC values were obtained from the normal allografts than those from AR
allografts. The ROC curve was constructed and demonstrated the best sensitivity and
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specificity at the b-value of 800 s/mm2. The functionality of 21 renal allografts was
assessed by Palmucci et al. [116]. Patients were divided into three groups by their CrCl
values and their ADCs and true diffusion (TD) were estimated with renal function indices.
Manual region of interests of the transplanted kidney for the three groups were placed and
the cortical ADC and TD were evaluated. A moderate positive correlation between the
CrCl and both the ADC and TD, as well as no difference between the ADC and TD values
for the contiguous groups have been found. The subsequent extension [117] of these
evaluations to 35 patients revealed a slightly smaller positive correlation than the
previously reported one [116]. However, acute rejection responses after transplantation
could not be detected.
Vermathen et al. [118] investigated the determination of long-term (3 years)
stability and potential changes for renal allograft recipients. Cortical and medullary region
of interests were selected and the ADC values were measured from all b-values. A
significant correlation between different ADC components was demonstrated in the case
of normal transplants. However, the Fp values were the highest, and the medullary Fp had
the greatest changes in the case of reduced transplants. Possible relations between the
selected laboratory results and diffusion parameters in the early period after kidney
transplantation was explored by Katarzyna et al. [119]. To overcome the DW-MRI T2“shine-through” [120], additional exponential ADCs were measured. These measurements
were conducted in the kidney’s cortex and medulla over multiple user-defined region of
interests at the b-values of 600 and 1000 s/mm2. They obtained the best-quality AD
measurement in the renal cortex at the b-value of 1000 s/mm2 because of the relative
variability of results and SNR. In addition, strong dependencies were observed between
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the ADC and exponential ADC, measured in the renal cortex at b1000 s/mm2, and the
estimated GFR. Kaul et al. [121] investigated renal dysfunction assessment using cortical
and medullary ADC maps. A significant decrease in ADC values of medullas compared to
those cortexes in normal donor kidneys and normal allografts was reported. Both the
medulla and cortex ADCs decreased or increased significantly for a rejection or the
recovery from the rejection itself, respectively. Abou-El-Ghar et al. [122] assessed renal
functionality for 70 renal allograft patients. DW-MRI scans at two b-values of 0 and 800
s/mm2 were performed for 49 patients with normal renal allografts (group 1) and 21
patients with acute graft impairment (group 2: 10 acute cellular rejection (ACR), 7 ATN,
and 4 immunosuppressive toxicity (IT) rejection types). In a single cross-section, a userdefined region of interest was placed at the middle of the kidney and a pixel-wise ADC
was calculated. Results shown that the ADC values of group 2 were significantly lower
than those of group 1, and no overlap was detected between the ADCs of group 1 and the
ATN patients of group 2. However, the minimal overlap was observed between the ADCs
of group 1 and the patients with the ACR and IT of group 2.
Detection of early renal allograft dysfunction caused by AR and ATN was exploited
by Liu et al. [107] using DW-MRI. With manually selected cortical and medullary region
of interests, lower ADC values of the AR group than those of the control groups were
revealed, whereas no difference in the ADC values between the AR and ATN groups was
detected. A similar earlier study was conducted by Thoeny et al. [123]. A recent study to
distinguish between rejection and non-rejection renal transplants was made by Shehata et
al. [124]. Their study included 36 renal transplants of which 6 were non-rejection and 30
were rejection. After DW-MRI data motion correction using a 2D B-splines approach, they
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segmented the largest coronal cross-section of the kidney using a fully automated level sets
segmentation approach. Then, they calculated the ADCs at different b-values from the
segmented coronal cross-section for each subject. By using a leave-one-subject-out
scenario along with a K Star classifier, they got an 87% total classification accuracy. In
addition, they depicted color-maps from the calculated ADCs for the visualization purpose
at different b-values. In a more recent study, Shehata et al. [125] determined renal rejection
type after transplantation using DW-MRI. In their study, 39 renal rejection transplants of
which 31 were TMR and 8 were ATN-AMR. Firstly, DW-MRI data co-alignment using a
3D B-splines approach, followed by kidney segmentation using geometric deformable
models were performed. Then, they calculated 3D cumulative distribution functions
(CDFs) from ADCs for the entire segmented kidney at different low and high b-values of
(10, 20, 30, 40, 50, 100) and (200 and 300) s/mm2, respectively. To account for blood
perfusion and water diffusion of the kidney, they fused the CDFs at low and high b-values
together. Finally, a 98% classification accuracy was obtained using a stacked nonnegativity constrained autoencoder (SNCAE) classifier along with a leave-one-subject-out
scenario.
iv.

MRI with specific contrast agent (Ultra small Superparamagnetic Particles of
Iron Oxide "USPIO")"

Ultra small Superparamagnetic Particles of Iron Oxide (USPIO) is a contrast agent
used in MRI that may one day be another tool that could be used to diagnose renal rejection
[126-132]. USPIO is said to be able to detect the amount of macrophage that is present in
the kidney and therefore tell whether the kidney is under stress and becoming rejected [126132]. The more macrophages that are present to absorb the particles through endocytosis,
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the weaker the USPIO signal will show on the MRI [126-129, 131, 132]. This technique
has not been used in human kidney transplant studies and is still in its infancy and more
studies should be performed. The present studies, which were done on rat models in vivo,
show some promise in diagnosing preclinical renal rejection [126, 127, 129, 131, 132].
Though there is some promise, USPIO at present lacks specificity, which means the signal
could be weakened by other conditions or substances that are found in the body other than
the presence of macrophage. Another reason why USPIO lacks specificity is that it cannot
determine why the macrophages are present at this time [126-132]. Even with some of
these downsides there are enough possible positive aspects of USPIO that more research
should be conducted. The next step for research of USPIO could be larger animal studies
whose kidneys are more closely related to humans. Once USPIO is proven relatively safe
and effective in large animal studies, human studies should be considered.
H. Conclusion
Though the treatment of chronic kidney disease has improved greatly with the use
of transplants, there are still challenges such as graft dysfunction that provide a challenge
in maintaining survival of the new organ. In the future, the use of image-based diagnosis
will be improved and implemented in the diagnosis of both pre- and post-transplantation.
It is hoped that by having these improved imaged based CAD systems that diagnosis of
graft dysfunction will be less invasive, more accurate, time saving, and inexpensive
compared to renal biopsies and other traditional methods of diagnosis. By having all of
these advantages it is expected that graft survival will improve in cases of graft dysfunction.
I. Thesis Organization
This thesis is presented in four chapter. The chapters are summarized as followed
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1. Chapter I
This chapter was an over view of the function of the kidney, what disorder can arise in
the kidney mainly CKD. It then discusses how CKD stage 5 is traditionally treated.
Transplantation provides the best outcome for patients however complications can arise
and the thesis discusses how graft dysfunction is presently diagnosed and the risk
associated with renal biopsies. Finally, we discussed the potential alternatives for
diagnosing graft dysfunction, mainly image based techniques such as DW MRI, BOLD
MRI, CE US, Ultrasound PD US, DCE MRI.
2. Chapter II
This chapter investigates which perimeters will proved the most accurate outcome
when diagnosing graft dysfunction while using the CAD system and a DW- MRI.
3. Chapter III
This chapter investigates the ability of the CAD system using DW-MRI to differentiate
between the ATN and T-celled mediated rejection.
4. Chapter IV
This chapter provides a conclusion for this thesis and mentions future plans for this
CAD system. This chapter also describes other applications other than its use in assessing
kidney function. CAD systems can be used for assessing and/or diagnosing prostate cancer,
lung injury, dyslexia and autism. .
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CHAPTER II
INVESTIGATING POSSIBLE SIGNIFICANT DIFFERENCES BETWEEN
REJECTION AN NON-REJECTED RENAL ALLOGRAFTS USING DIFFUSIONWEIGHTED MRI
A. Overview
The main goal of this study was to determine which parameters were correlated
with a more accurate diagnosis of renal rejection in patients who have undergone kidney
transplantation, using 4D (3D+b-value) diffusion-weighted MRI (DW-MRI).
The study included 16 patients with stable renal allograft function (Group 1) and
37 patients with rejected allografts (Group 2), determined by renal biopsy post
transplantation. All patients’ kidneys were evaluated using diffusion-weighted magnetic
resonance imaging (DW-MRI) coupled with a computer aided diagnostic (CAD) system,
which integrates both clinical and MRI-derived biomarkers. In order to extract the MRIbased biomarkers, the developed CAD system performs multiple image processing steps,
including MRI data alignment to handle the motion effects coming from breathing and
heartbeat, kidney segmentation using a geometric (level-set based) deformable model, and
estimation of image-based functional biomarkers called apparent diffusion coefficients
(ADCs) for the segmented kidney at different gradient field strengths and durations (i.e. bvalues of 50 and from 100 to 1000 with a step of 100 s/mm2). Kidneys were studied for
any areas of diffusion restriction. Radiologists interpreted the images of the DW-MRI
without prior knowledge of the results of the renal biopsy. Statistical
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analyses were performed to investigate possible correlations between renal allograft
biomarkers and the biopsy diagnosis. The statistical analysis examined four categories of
parameters: (i) clinical biomarkers (i.e. plasma creatinine (SPCr) and creatinine clearance
(CrCl)) alone, (ii) the mean apparent diffusion coefficient (ADC) at 11 different individual
b-values (b50 , and b100 to b1000 with step of 100 s/mm2), (iii) all possible combinations
of the mean ADCs of individual b-values (i.e. 211sub-models), and (iv) the fusion of the
clinical biomarkers with the mean ADC of fused b-values (the full model) .
By using ANOVA along with the likelihood ratio (χ2) tests, SPCr and CrCl were
found to have a significant effect on the likelihood of acute rejection, as did the mean ADC
for individual b-values of 500, 600, 700, and 900 s/mm2. However, patient age, sex, and
mean ADC at other b-values were not statistically significant. The reduced model
incorporating only ADC at b-values of 100 and 700 s/mm2 together had the lowest Akaike
information criterion (AIC) of 58.6, and mean ADC at those same two b-values were the
most informative predictors of acute rejection according to their Akaike weighting. For
comparison, the top 10 sub-models and the full model were reported.
Preliminary findings suggest that the most statistical significant individual b-values
are b-values of 500, 600, 700, and 900 s/mm2. On the other hand, the most informative
model for diagnosing acute renal rejection using DW-MRI was the model that combines
only the mean ADCs at b-values of 100 and 700 s/mm2 together along with the clinical
biomarkers.
B. Introduction
The kidney is a significant organ playing vital roles in the maintenance of
electrolytes, acid-base balance, and blood pressure. It is the primary filtration organ in the
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human body, keeping in the nutrients that the body needs and expelling out the unwanted
toxic wastes. A reduction of kidney function can occur naturally as a result of age or as a
result of acute kidney injury or chronic disease (CKD). The primary causes of CKD can
be attributed to diabetes and hypertension. However other genetic (polycystic kidney
disease or APOL1 nephropathy) or autoimmune (lupus nephritis or primary glomerular
nephritis) diseases [1].

While the primary insult may influence the rate of CKD

progression, the net effect of the unremitting accelerated loss of the kidney function is the
build-up of uremic toxins in the body. The complete or near-complete loss of the kidney’s
ability to ultrafilter the blood and product urine is referred to as end-stage kidney disease
(ESKD). Treatment of ESKD to address the deadly build-up of toxins is achieved thru
renal replacement therapy- dialysis or transplantation. Both of these approaches have
inherent life altering complications. Hence preserving the health of this organ is of the
utmost importance.
The prevalence in the United States (2010-2014) of CKD was about 14.8% of the
adult population and 680,000 cases of ESKD.

Due to a limitation in available

transplantable kidneys only approximately 17,000 yearly transplants were performed
during this time [2, 3]. Though this has immensely improved the outcome of patients
diagnosed with stage 5 CKD (ESKD), there are still complications that can occur. One of
the main concerns is graft dysfunction. Routine post-transplantation clinical evaluation of
kidney function is of great importance to prevent the graft loss. The diagnostic technique
presently recommended by the National Kidney Foundation (NKF) to measure overall
kidney function is glomerular filtration rate (GFR), which is based on measuring the serum
creatinine level. However, this test has low sensitivity and is a late biomarker for renal
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dysfunction (a significant change in serum creatinine level is detectable only after the loss
of 60% of renal function), and it does not assess the function of individual kidneys [4]. The
current gold standard for acute rejection (AR) diagnosis is a renal needle biopsy. However,
it is invasive, difficult to perform, costly, and a time-consuming procedure. It can also
result in over- or under-estimates of AR by only sampling small kidney areas. Thus, the
need for new noninvasive techniques to assess renal transplant status with the capability to
provide accurate and early diagnosis of AR is of great clinical importance. A promising
methodology to diagnose graft dysfunction, without complications, is to utilize imaging
techniques such as diffusion-weighted magnetic resonance imaging (DW-MRI) with the
assistance of computer aided diagnostic (CAD) systems.
In recent years, developing noninvasive image-based CAD systems for renal
transplant assessment has been an area of increased research. For example, scintigraphy or
radionuclide, the traditional methods in renal imaging, has been clinically used to
qualitatively and quantitatively evaluate graft function [57]. However, due to its limited
spatial resolution, it fails in showing accurate anatomical details, so functional
abnormalities inside different parts of the kidney (such as cortex and medulla) cannot be
discriminated precisely [58]. Furthermore, radionuclide imaging includes radiation
exposure [59], thus limiting the range of its applications [60]. Computed tomography (CT)
is a commonly available technology that uses contrast agents and allows accurate
evaluation of various diseases in renal transplantation [61]. However, information gathered
by CT to detect acute rejection (AR) is unspecific and the contrast agents used are still
nephrotoxic. Therefore, CT currently has a limited role in diagnosing AR [62]. The
aforementioned shortcomings make these imaging techniques impractical for clinical use,
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which has led to the use of alternative imaging techniques to assess renal transplant
functionality, namely the ultrasound (US) and MRIs.
In contrast to radionuclides and CTs, US is a safer imaging technique for the
diagnosis of kidney diseases. However, US suffers from low signal-to-noise ratios (SNRs),
shadowing artifacts, and speckles that greatly decrease image quality and diagnostic
confidence. Moreover, conventional US parameters are not exact indicators of renal graft
dysfunction, and it could only provide a prognostic marker of the graft [75, 76] or even a
similar indication like other diagnostic possibilities, such as acute tubular necrosis [66, 77].
These shortcomings have been circumvented recently by evaluating kidney functions with
MRI, which allows advanced analysis of different aspects of renal function. There are
various types of MRI scans that are used for renal transplant assessment. While some of
them provide only anatomical information, other MRI modalities, such as dynamic
contrast-enhanced (DCE) and diffusion-weighted (DW) MRI, provide both anatomical and
functional kidney information. Clinically, nephrologists recommend the use of DCE-MRI
if the eGFR is greater than 30 ml/min only, because the contrast agent may be nephrotoxic
for those patients with a eGFR less than 30 ml/min. To account for all eGFR variability
and to cover all those kinds of patients, DW-MRI is recommended. Therefore, we focused
our study on the use of DW-MRIs as a diagnostic tool. Briefly, we will review some of the
existing studies that used DW-MRI in diagnosing acute renal transplant rejection.
Lately, DW-MRI has become a subject of extensive research as an emerging
imaging modality for renal function assessment thanks to DW-MRI’s ability to provide
both anatomical and functional information. For DW-MRI, its functional parameter, called
apparent diffusion coefficient (ADC), is estimated from different gradient field strengths
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and durations (b-values) to describe the unique tissue characteristics of inner spatial water
behavior [112]. Therefore, multiple studies have utilized DW-MRI to assess renal
functionality by measuring the ADC values, however the results have been mixed [107].
The aim of this study is to determine which parameters are correlated with a more
accurate diagnosis of renal rejection in patients who have undergone kidney
transplantation, using 4D (3D+b-value) DW-MRI.
C. Materials
The Institutional Review Boards of the University of Louisville approved the study
protocol (IRB protocol # XY.ABCD). A total of 53 patients undergoing kidney
transplantation provided consent to participate in this study with all scans and biopsies
preformed from July 2014 to June 2015. All kidney transplants were performed at
University of Mansoura, Egypt and the donated kidneys were from live donors. Patient
characteristics including sex (44 males and 9 females); mean age (26.26 +/- 9.87 years
(range, 12-54 years). Patients were divided into these groups (group 1 and group 2). Group
1 (19 patients) included patients with healthy graft function as indicated by their renal
biopsies. In Group 1 three patients were excluded from the study due to technical problems
yielding total of 16 non-rejection renal transplants. All patients were evaluated by renal
biopsy after DW-MRI
Group 2 (41patients) included patients with acute renal rejection, based on renal
biopsy histology. In group 2 a total of 4 patients were excluded from the study due to
technical problems, yielding a total of 37 patients with rejection allografts. All patients
underwent DW-MRI and renal biopsy which were performed together, respectively. Both
DW-MRI and biopsy were included in the final analysis and examined by a nephrologist
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and a radiologist. Details of DW-MRI demographics and statistics are documented in Table
1.
Table 1
Demographics statistics of the DW-MRI data for the 53 renal transplant patient included
in the study.
(N=53)

Overall

Non-Rejected Rejected

Age in years Mean (SD)

26.26415094

25.125

26.75675676

(9.87)

(10.07)

(9.89)

Male

44 (83)

12 (75)

32 (86)

Female

9 (17)

4 (25)

5 (14)

10-19

15 (28)

5 (31)

10 (27)

20-29

19 (36)

7 (44)

12 (32)

30-39

14 (26)

2 (13)

12 (32)

40-49

4 (7)

2 (13)

2 (5)

50-59

1 (2)

0 (0)

1 (3)

10-19

3 (6)

1 (6)

2 (5)

20-29

4 (8)

0 (0)

2 (5)

30-39

4 (8)

1 (6)

3 (8)

40-49

3 (6)

1 (6)

2 (5)

50-59

6 (11)

0 (0)

6 (16)

60-69

9 (17)

0 (0)

9 (24)

70-79

13 (25)

7 (44)

6 (16)

80-89

6 (11)

2 (4)

4 (11)

90-99

2 (4)

1 (6)

1 (3)

100-109

2 (4)

1 (6)

1 (3)

Gender N (%)

Age category N (%)

Serum Creatinine Clearance
(%)
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110-119

2 (4)

2 (4)

0 (0)

0.0-0.9

4 (8)

3 (19)

1 (3)

1.0-1.9

37 (70)

10 (63)

27 (73)

2.0-2.9

8 (15)

2 (13)

6 (16)

3.0-3.9

1 (2)

0 (0)

1 (3)

4.0-4.9

2 (4)

0 (0)

2 (5)

5.0-5.9

1 (2)

1 (6)

0 (0)

Plasma Creatinine (%)

1. MRI Protocol
The MRI study was performed using a 1.5T scanner (SIGNA horizon, General
Electric Medical systems, Milwaukee, WI). DW-MR images were obtained by using a
body coil and a gradient multi-shot spin-echo echo-planar sequence (TR/TE, 8000/61.2;
bandwidth, 142 kHz; matrix, 1.25×1.25 mm2; section thickness, 4 mm; intersection gap, 0
mm; FOV, 32 cm; signals acquired, 7; water signals acquired at different b-values of (b0,
b50, b100, b200, b300, b400, b500, b600, b700, b800, b900, and b1000) s/mm2.
Approximately 50 sections have been obtained in 60 - 120 s to cover the whole kidney.
D. Methods
The ultimate goal of this study is to determine which parameters are correlated with
a more accurate diagnosis of AR in patients who have undergone kidney transplantation,
using 4D (3D+b-value) DW-MRI. To move towards this goal, all patients’ kidneys were
evaluated using DW-MRI coupled with a CAD system, which integrates both clinical
biomarkers (e.g., serum plasma creatinine (SPCr) and creatinine clearance (CrCl) and DWMRI physiological biomarkers; namely, apparent diffusion coefficients (ADCs). Then,
statistical analysis was performed to investigate possible correlations between renal
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allograft biomarkers and the biopsy diagnosis of either AR or non-rejection (NR) renal
transplant. Details are outlined below.
1. DW-MRI Image Analysis
An important and significant advantage of DW-MRI is the ability to interrelate
local blood diffusion characteristics with the transplant status. This advantage is achieved
through the DW-MRIs ability to measure unique tissue characteristics of inner spatial water
behavior called apparent diffusion coefficient (ADC) [133], which can be used to assess
the transplant status. In order to obtain accurate estimation of the DW-MRI-derived
markers, namely ADCs, the developed CAD system [124, 134] performs multiple image
processing steps. First, in this study the noise effects and image inhomogeneity was
reduced first for a given DW-MRI data by applying an intensity histogram equalization
and the nonparametric bias correction technique [135]. This was followed by a 3D Bsplines based non-rigid registration [136] to handle kidney motion to reduce the DW-MRI
data variability across subjects. Then, the kidney as segmented using a geometric (levelset based) deformable model [137-139]. After segmenting kidneys, the ADCs [140] were
estimated at different gradient field strengths and durations (b-values, in our case 11 bvalues) [134]. Furthermore, our CAD system was also designed to demonstrate the local
voxel-wise diffusion of the segmented DW-MRI data as color maps. These regional display
mappings will be of great importance for the radiologists to help investigate which region
of the kidney needs attention and follow-up with appropriate treatment. Figures 9&10
demonstrates the voxel-wise parametric maps for the diffusion of the transplanted kidney
for a NR case and an AR case, respectively. The data in Figures 9&10 reveals the expected
relation of the DW-MRI parameters for NR versus AR status.
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Figure 9. Illustration sample for a non-rejection subject, where (a) the raw data at the bvalue of 0 s/mm2, (b) the segmented kidney object at the b0 s/mm2, and (c) the average
voxel-wise diffusion parametric maps across the subject.
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Figure 10. Illustration sample for a rejection subject, where (a) the raw data at the b-value
of 0 s/mm2, (b) the segmented kidney object at the b0 s/mm2, and (c) the average voxelwise diffusion parametric maps across the subject.
2. Statistical Analysis
After the DW-MRI-derived markers were estimated (i.e. ADCs), statistical analysis
was performed to investigate possible correlations between renal allograft biomarkers and
the biopsy diagnosis. The statistical analysis examined four categories of parameters: (i)
clinical biomarkers (i.e. serum plasma creatinine (SPCr) and creatinine clearance (CrCl))
alone, (ii) the mean apparent diffusion coefficient (ADC) at 11 different individual b-values
(b50, and b100 to b1000 with step of 100 s/mm2), (iii) all possible combinations of the
mean ADCs of individual b-values (i.e. 211sub-models), and (iv) the fusion of the clinical
biomarkers with the mean ADC of fused b-values (the full model).
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Statistical calculations were performed using R version 3.1.1. The relationship of
graft tolerance to ADC was tested using logistic regression of biopsy result (acute rejection
or non-rejection) against demographic, laboratory, and imaging parameters. The full model
included age and sex, SPCr and CrCl, and mean ADC at each b-value. Statistical
significance of each parameter was assessed using likelihood ratio (χ2) tests. Variable
subset selection was performed using the Akaike information criterion (AIC). All 2 11
models were tested, considering all possible subsets of mean ADC, and the model yielding
the lowest AIC was selected as the most informative. However, some questions have to be
answered regarding the statistical significant difference between the non-rejection (NR)
and the early rejection (ER) renal transplants using: (i) the clinical biomarkers (i.e. SPCr
and CrCl) alone, (ii) the mean ADCs at different individual 11 b-values from (b50 to
b1000). In addition, two more questions need to be answered regarding how informative
the built model is using: (i) the mean ADCs of a certain group of individual b-values (submodel), and (ii) the fusion of the clinical biomarkers with the mean ADCs of fused b-values
(the full model).
E. Results
ANOVA found that SPCr (χ2 = 10.1, p = 0.002) and CrCl (χ2 = 14.1, p = 0.0002)
had a significant effect on the likelihood of acute rejection, as did the mean ADC for b =
500 s/mm2 (χ2 = 3.98, p = 0.0461), b = 600 s/mm2 (χ2 = 5.81, p = 0.0159), b = 700 s/mm2
(χ2 = 5.65, p = 0.0174), and b = 900 s/mm2 (χ2 = 4.94, p = 0.0262). Patient age, sex, and
mean ADC at other b-values were not statistically significant, as shown in Table 2. The
reduced model incorporating only ADC at b = 100 s/mm2 and at b = 700 s/mm2 had the
lowest AIC = 58.6, as shown in Table 3, and mean ADC at these same two b-values were
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the most informative predictors of acute rejection according to their Akaike weighting (see
Figure 11). For comparison, the full model AIC = 65.0.
Table 2.
Results of analysis of covariance on the logistic regression model for acute rejection.
ADCn: mean ADC at b = n; SPCr: serum plasma creatinine; CrCl: creatinine clearance.
Variable

χ2

p-value

ADC50

2.618

0.106

ADC100

3.791

0.0515

ADC200

0.610

0.435

ADC300

1.242

0.265

ADC400

0.016

0.899

ADC500

3.978

0.0461

ADC600

5.813

0.0159

ADC700

5.654

0.0174

ADC800

1.446

0.229

ADC900

4.944

0.0262

ADC1000

0.087

0.769

Age

0.846

0.358

Sex

2.291

0.130

SPCr

14.068

0.000176

CrCl

10.070

0.00151
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Table 3
Mean ADC included in the models with the 10 lowest AIC values. The full model and the
model with demographics only and lab results are shown for comparison. Δ = AIC − min
AIC.
Δ

Predictor variables (b-value)
50

100

200

300

400

500

0
0.04
0.57
0.96
1.04
1.14
1.16
1.20
1.28
1.39
3.29
6.40

50

600

700

800

900

1000

Figure 11. The Akaike weighting criterion versus the sub-models at different b-values,
reflects how much informative each sub-model is.
F. Discussion and Conclusions
Using 4D (3D+b-value) diffusion-weighted MRI (DW-MRI) we determined the
statistical significance of measured parameters (biomarkers, mean ADC at different
individual b-values (b50 to b1000), sub-models, and full model) that correlated with renal
rejection in patients who had undergone kidney transplantation. We hypothesized the most
accurate parameters for diagnosing would be the full model, due the fact that all the mean
ADC of each b-value would have been fused giving all the information of the scan and
therefore giving the whole picture. To the best of our knowledge, this is the first time the
full model and sub model parameters have been implemented. Based on the AIC the most
accurate parameters would be the sub model which fuses b=100 s/mm2 and b=700 s/mm2.
All other parameter’s accuracy lies in between sub-model fused b=100 s/mm2 and b=700
s/mm2 and full model. A study by Liu et al. [107] explored the detection of early renal
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allograft dysfunction caused by AR using DW-MRI. With manually selected medullary
and cortical regions of interests (ROIs), lower ADC values of the AR group than those of
the control groups were revealed. A similar earlier study was conducted by Thoeny et al.
[123] Xu et al. [115] investigated the potential power of DW-MRI to diagnose AR renal
allografts on 26 biopsy-proven rejection and 43 non-rejection patients. They found that
higher ADC values were obtained from the normal allografts compared to those from AR
allografts. The receiver operating characteristic (ROC) curve was constructed and
demonstrated the best sensitivity and specificity at the b-value of 800 s/mm2
A study by Hueper et al. [114] was conducted to assess renal allografts functionality
included 64 patients with renal allografts, of which 33 were patients with initial graft
function (IGF) and 31 were patients with delayed graft function (DGF). These patients
underwent DW-MRI scans at two b-values (0 and 600 s/mm2). After placement of manual
region of interests in the lower, middle, and upper poles of the medulla and cortex on
several portions to cover large regions of the allograft and estimation of renal diffusion
parameters, including ADC, they concluded that renal diffusion parameters were
significantly reduced in patients with DGF and their values well correlated with renal
function in biopsy specimens. Likewise, a recent study by Eisenberger et al. [113] was also
conducted to evaluate renal allograft functionality. They began with a manual placement
of region of interests. Then they calculated the means and standard deviations of the ADCs
from all b-values. A significant reduction in these parameters was observed in the cortex
and the medulla for the AR patients, and the previously stated parameters were correlated
with the creatinine clearance (CrCl) values. Kaul et al. [121] examined renal dysfunction
assessment using cortical and medullary ADC maps. They found a significant decrease in
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ADC values of medullas compared to those cortexes in normal donor kidneys and normal
allografts. Both the cortex and medulla ADCs decreased or increased significantly for the
recovery from the rejection itself or a rejection, respectively. Abou-El-Ghar et al. [122]
assessed renal functionality for 70 renal allograft patients. DW-MRI scans at two b-values
of 0 s/mm2 and 800 s/mm2 were performed for 49 patients with normal renal allografts
(group 1) and 21 patients with acute graft impairment (group 2). In a single cross-section,
a user-defined region of interest was placed in the middle of the kidney and a pixel-wise
ADC was calculated. Results show that the ADC values of group 2 were significantly lower
than those of group 1. Possible relations between the selected laboratory results and
diffusion parameters in the early period post kidney transplantation was explored by
Katarzyna et al. [119]. These measurements were conducted in the kidney’s cortex and
medulla over multiple user-defined region of interests at the b-values of 600 and 1000
s/mm2. They obtained the best-quality ADC measurement in the renal cortex at the b-value
of 1000 s/mm2 because of the relative variability of results and signal-to-noise ratio (SNR).
In addition, strong dependencies were observed between the ADC and exponential ADC,
measured in the renal cortex at b1000 s/mm2, and the estimated GFR. Vermathen et al.
[118] inspected the determination of long-term (3 years) stability and potential changes for
renal allograft recipients. Cortical and medullary region of interests were designated and
the ADC values were measured from all b-values. A significant correlation between
different ADC components was demonstrated in the case of normal transplants.
In conclusion, our study demonstrated that by fusing specific b-values one can get
a more accurate picture than if one were to use a single b-value or that of fusing all b-values
together. Our analysis has also shown that our CAD system utilizing DW-MR images,
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holds a promise as a reliable non-invasive diagnostic tool. In the future, we plan to test the
proposed CAD system on a larger and more diverse cohort of patients to confirm the
accuracy and robustness of the proposed technique. In addition, new data set with lower bvalues will be included to investigate whether these lower b-values will be more helpful in
finding more significant differences between non-rejection and rejection transplants.
Furthermore, the ability of the developed technique needs to be examined in diagnosing
different types of rejection for proper treatment administration
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CHAPTER III
A NEW NON-INVASIVE APPROACH FOR EARLY CLASSIFICATION OF RENAL
REJECTION TYPES USING DIFFUSION-WEIGHTED MRI
A. Overview
Although renal biopsy remains the gold standard for diagnosing the type of renal
rejection, it is not preferred due to its invasiveness, recovery time (1-2 weeks), and potential
for complications, e.g., bleeding and/or infection. Therefore, there is an urgent need to
explore a non-invasive technique that can early classify renal rejection types. In this
chapter, we develop a computer-aided diagnostic (CAD) system that can classify acute
renal transplant rejection (ARTR) types early via the analysis of apparent diffusion
coefficients (ADCs) extracted from diffusion-weighted (DW) MRI data acquired at low(accounting for perfusion) and high- (accounting for diffusion) bvalues. The developed
framework mainly consists of three steps: (i) data co-alignment using a 3D B-spline-based
approach (to handle local deviations due to breathing and heart beat motions) and
segmentation of kidney tissue with an evolving geometric (level-set based) deformable
model guided by a voxel-wise stochastic speed function, which follows a joint kidneybackground Markov-Gibbs random field model accounting for an adaptive kidney shape
prior and visual kidney-background appearances of DW-MRI data (image intensities and
spatial interactions); (ii) construction of a cumulative empirical distribution of ADC at low
and high b-values of the segmented kidney accounting for blood perfusion and water
diffusion, respectively, to be our discriminatory ARTR types feature; and (iii)
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classification of ARTR types (acute tubular necrosis (ATN) anti-body- and T-cellmediated rejection) based on deep learning of a non-negative constrained stacked
autoencoder. Results show that 98% of the subjects were correctly classified in our “leaveonesubject-out” experiments on 39 subjects (namely, 8 out of 8 of the ATN group and 30
out of 31 of the T-cell group). Thus, the proposed approach holds promise as a reliable
non-invasive diagnostic tool.
B. Introduction
Acute renal rejection, i.e. the immunological response of the body to a foreign
kidney, is the most serious cause of renal dysfunction [141]. Medicine has come very far
in the treatment of CKD and renal failure with the evolution of kidney transplants, which
has significantly improved patient outcomes and quality of life. In the U.S., approximately
17,000 renal transplants are performed annually, and given the limited number of donors,
the salvage of a transplanted kidney is very important [141]. Although transplants can
improve a patient’s well-being, there is a potential risk of kidney rejection by the patient
leading to a loss of graft function, and, if not treated in a timely manner, even death [142,
143]. Therefore, early determination of the type of renal rejection is crucial for the
identification of proper treatment to administer. As a reminder, the different types of renal
rejection include: (i) acute tubular necrosis (ATN) anti-body mediated rejection; (ii) T-cell
mediated rejection; (iii) immunosuppressive toxicity (IT); and (iv) viral infection (VI).
Each of these rejection types has its own specific treatment procedure and the existence of
two types of rejection at the same time further complicates and slows down the treatment
process [41].
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Currently, renal biopsy is the most definitive technique for diagnosing renal
rejection type. However, there are a number of significant drawbacks to this method;
specifically, this procedure is invasive and expensive, increases the potential morbidity
rate, prolongs recovery time (one to two weeks), and has a high probability for over- or
under- estimating the extent of inflammation in the entire graft [141]. Hence, a noninvasive imaging technique coupled with computer-aided diagnostic (CAD) techniques
holds a lot of promise due to its ability to simultaneously provide information on each
kidney separately, speed of analysis, and decrease in patient morbidity, healthcare costs,
and patient recovery time.
A number of different methodologies are being implemented to assess kidney
function. In particular, diffusion-weighted (DW) MRI is an emerging imaging technology
that is based on the measurement of water molecules inside soft tissue [112]. The main
advantage of DW-MRI is its ability to provide both anatomical and functional information,
while avoiding radiation exposures and contrast agents administration. Several studies
have utilized DW-MRI for functional renal assessment by measuring the cortical apparent
diffusion coef- ficient (CADC) and medullary ADC (MADC), but the results have varied
[144]. As a result, none of the studies appear to indicate any difference between the types
of renal impairment except for the study by Abou-El-Ghar et al. [122] which showed a
distinctive pattern. Their study consists of 21 patients with acute graft impairment with 10
Tcell, 7 ATN, and 4 IT rejection types. A region of interest (ROI) is placed at the middle
of the kidney in a single cross-section including the entire renal parenchyma, but excluding
the renal sinus. For kidney images with an abnormal focal area and high signal intensity,
another region of interest is selected separately. On a pixel-by-pixel basis, the ADC values
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for the patients are calculated from the three groups, which demonstrate that the ADC of
ATN appears as heterogeneous, a mosaic pattern with a tiger stripe appearance. The
investigators conclude that under low b-values, ADC values are influenced by both
diffusion and blood perfusion, while under high b-values, the influence of blood perfusion
is avoided. Another study by Eisenberger et al. [113] investigates manually placing the
region of interests in the upper, mid, and lower poles of the cortex and medulla on several
slices to cover large regions of the allograft. Then, all individual region of interests are
merged to yield one region of interest for the cortex and one for the medulla. Mean and
standard deviations of ADCs are calculated for the five patients, four of which have AR
and one has ATN. However, due to the lack of patients with transplant dysfunction, the
investigators proposed that the trend indirectly indicates possible differences between the
AR and the ATN groups. Two additional studies [145, 110] conclude that perfusion MRI
demonstrates a significant decrement in renal perfusion of AR allografts, but not in ATN
allografts. While other studies [122, 113] support the premise that both the levels of water
diffusion and blood perfusion are impaired in AR allografts, whereas only the level of water
diffusion is impaired in the ATN allografts.
In addition to DW-MRI, another imaging technique blood Oxygen level-dependant
(BOLD) MRI has been utilized to study renal rejection, using the amount of oxygen
diffused blood in the kidney to examine the proper functionality of the kidney. Namely,
the amount of deoxyhemoglobin is measured by the apparent relaxation rate (ARR)
parameter [144]. Some studies find that the ATN kidneys have higher medullary ARR
values than those of AR [144, 108–110], while others have discovered that kidneys with
ATN have higher cortical ARR values than those with AR [109]. Nonetheless, the general
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consensus appears to be one in which higher ARR values. All of the aforementioned
clinical statistical analysis studies have some limitations. For example, the methods employ
a manual delineation of the kidney using a 2D region of interest, which makes this
delineation subjective. In addition, the methods are unable to compensate for the motion
of the kidney since the methods did not account for the whole kidney. Furthermore, several
of the studies performed only a statistical analysis to investigate the significant difference
between pairs at certain b-values. Finally, the studies mentioned above did not investigate
the fusion of ADC at multiple low and high b-values.
Therefore, to overcome these limitations, we are developing a fully automated CAD
system, shown in Figure 12, with the ability to: (i) delineate the whole kidney and handle
its motion; and (ii) implement a stacked autoencoder to fuse the ADC values that have been
calculated from the segmented DW-MRI data at low and high b-values. Experimental
results, shown in, “Experimental Results,” hold promise of the developed CAD system as
a reliable non-invasive diagnostic tool. To the best of our knowledge, this is the first CAD
system of its kind to distinguish between different types of ARTR.
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Figure 12. Block-diagram of the proposed framework for kidney rejection types
classification from diffusion weighted MRI
C. Methods
Starting from a given input DW-MRI data, our CAD system classifies T-Cell from
ATN mediated rejection kidneys in the following three steps: (i) segmenting kidney tissues
from surrounding abdominal structures (“Preprocessing, Co-Aligment, and 3D Kidney
Segmentation); (ii) estimating voxel-wise physiological parameters (ADC) to form a 3D
parametric map for detecting the type of rejected kidney (“Estimating and Depicting
Diffusion Parameters”); and (iii) classifying T-Cell from ATN rejection kidney status to
evaluate the proposed CAD system as a diagnostic test (“Autoencoding and Deep
Learning-Based Classifier”).
1. Preprocessing, Co-alignment, and 3D Kidney Segmentation
Initially, we reduce noise effects and DW-MRI heterogeneity by applying an
intensity histogram equalization and the nonparametric bias correction method proposed
in [135] on each DW-MRI sequence. Then, a 3D B-splines based transformation [136]
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using the sum of square difference (SSD) as a similarity metric is applied to handle kidney
motions, and thus get more accurate segmentation. Finally, we used the 3D kidney
segmentation approach proposed in [137] using level-sets from DW-MRI. To provide the
voxel-wise guidance of the level-sets, three features are integrated into a joint MGRF
model [146], namely, regional appearance [147, 148], shape, and spatial DW-MRI features
as shown in Figure 13. More details about our segmentation approach can be found in [137,
124].

Figure 13. Illustration of Joint MGRF estimation guiding the level-set segmentation
technique
2. Estimating and Depicting Diffusion Parameters
After segmenting the kidneys, their discriminatory physiological features are
estimated from the images and used to distinguish between ATN and T-cell of ARTR types.
This paper uses the ADC defined by Le Bihan [140] as a rejection transplant status feature:
𝐴𝐷𝐶𝑝 = 𝑏

1

0 −𝑏

𝑔𝑏:𝑝

ln (𝑔0:𝑝 ) =

ln 𝑔𝑏:𝑝−ln 𝑔0:𝑝
𝑏0 −𝑏

where p = (x, y, z) denotes a voxel at position
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with discrete Cartesian coordinates (x, y, z), and the segmented DW-MR images g0 and gb
were acquired with the b0 and a given different b-value, respectively.

Figure 14. Empirical ADC distributions and their CDFs for one rejection subject at
different b-values of (b50, b100, b200, and b300) s/mm2.
In order to reduce data dimensionality for the rejection transplant status
classification, we characterize the entire 3D ADC maps, collected for each subject at the
different b-values, by the CDFs of the ADCs, as shown in Figure 14. Differentiation
between rejection types can be obtained using DW-MRI acquired at low and high b-values.
In this paper, we constructed the CDFs at low and high b-values of (b10, b20, b30, b40,
b50, b100) and (b200 and b300), respectively, to classify the type of rejection. The training
CDFs are used for deep learning of a stacked non-negativity constrained autoencoder
(SNCAE) classifier detailed in, “Autoencoding and Deep Learning-Based Classifier.”
3. Autoencoding and Deep Learning-Based Classifier
To classify the rejection transplant status, our CAD system employs a deep neural
network with a stack of autoencoders (AE) before the output layer that computes a softmax
regression, generalizing the common logistic regression to more than two classes. Each AE
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compresses its input data to capture the most prominent variations and is built separately
by greedy unsupervised pre-training [149]. The softmax output layer facilitates the
subsequent supervised backpropagation-based fine tuning of the entire classifier by
minimizing the total loss (negative log-likelihood) for given training labeled data. Using
the AEs with a non-negativity constraint (NCAE) [150] yields both more reasonable data
codes (features) during its unsupervised pre-training and better classification performance
after the supervised refinement.

Figure 15: Block-diagram of an NCAE (a) and SNCAE (b) classifier
Let W = {We j ,Wd i : j = 1,...,s; i = 1,...,n} denote a set of column vectors of
weights for encoding (e) and decoding (d) layers of a single AE in Figure 15. Let T denote
vector transposition. The AE converts an n-dimensional column vector u = [u1,...,un] T of
input signals into an s-dimensional column vector h = [h1,...,hs] T of hidden codes
(features, or activations), such that s n, by a uniform nonlinear transformation of s weighted
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𝑇

𝑒
linear combinations of signals: ℎ𝑗 = 𝜎((𝑊𝑗𝑒 ) 𝑢) ≡ 𝜎(∑𝑛𝑖=1 𝑤𝑗:𝑖
𝑢𝑖 )where σ(...) is a certain

sigmoid, i.e. a differentiable monotone scalar function with values in the range [0, 1] .
Unsupervised pretraining of the AE minimizes total deviations between each given training
input vector uk; k = 1,...,K, and the same-dimensional vector, uW:k reconstructed from its
code, or activation vector, hk (Figure 15(a)). The total reconstruction error of applying such
AE to compress and decompress the K training input vectors integrates the 2-norms of the
1

deviations:𝐽𝐴𝐸 (𝑊) = 2𝐾 ∑𝐾
̂𝑤: 𝑘 − 𝑢𝑘 ‖2 To reduce the number of negative weights
𝑘=1‖𝑢
and enforce sparsity of the NCAE, the reconstruction error of Eq. (2) is appended,
respectively, with quadratic negative weight penalties, f(wi) = (min{0, wi}) 2 ; i = 1,...,n,
and Kullback-Leibler (KL) divergence, JKL(hWe ; γ), of activations, hWe , obtained with
the encoding weights We for the training data, from a fixed small positive average value,
γ, near 0: 𝐽𝑁𝐶𝐴𝐸 (𝑊) = 𝐽𝐴𝐸 (𝑊) + 𝛼 ∑𝑠𝑗=1 ∑𝑛𝑖=1 𝑓(𝑤𝑗:𝑖 ) + 𝛽𝐽𝐾𝐿 (ℎ𝑤𝑒;𝛾 )Here, the factors α ≥
0 and β ≥ 0 specify relative contributions of the non-negativity and sparsity constraints to
ℎ𝑤𝑒 :𝑗

the overall loss, JNCAE(W), and 𝐽𝐾𝐿 (ℎ𝑤 𝑒 : 𝑗𝑙𝑜𝑔 (

𝛾

) + (1 − ℎ𝑤 𝑒 : 𝑗)log(

1−ℎ𝑤 𝑒 :𝑗
1−𝛾

)

The classifier is built by stacking the NCAE layers with an output softmax layer,
as shown in Figure 15(b). Each NCAE is pre-trained separately in the unsupervised mode
by using the activation vector of a lower layer as the input to the upper layer. In our case,
the initial input data consisted of the 8 CDFs, each of size 100, i.e. n = 800. We calculated
the minimum ADC value, the maximum ADC value, and the minimum increment value;
thus, we have the step value. Then, we constructed each CDF as 100 regions based on the
calculations using the aforementioned parameters in order to not waste any information
from the ADCs and, thus, making our data well presented. The bottom NCAE compresses

64

the input vector to s1 first-level activators, compressed by the next NCAE to s2 secondlevel activators, which are reduced in turn by the output softmax layer to s◦ values.
Separate pre-training of the first and second layers by minimizing the loss of Eq.
(3) reduces the total reconstruction error, as well as increases sparsity of the extracted
activations and numbers of the non-negative weights. The activations of the second NCAE
layer, h[2] = σ(We [2] Th[1]), are inputs of the softmax classification layer, as sketched in
Figure 14(b) to compute a plausibility of a decision in favor of each particular output class,
𝑇 ℎ [2] )
exp(𝑊𝑜:𝑐

c = 1, 2: 𝑝(𝑐; 𝑤𝑜:𝑐 ) = exp(𝑊 𝑇

𝑜:1 ℎ

[2] )+exp(𝑊 𝑇 ℎ [2]
𝑜:2

; 𝑎𝑛𝑑 𝑐 = 1,2; ∑2𝑐=1 𝑝(𝑐; 𝑊𝑜:𝑐 ; ℎ[2] ) = 1.Its

separate pre-training minimizes the total negative log-likelihood J◦(W◦) of the known
training

classes,

appended

with

the

negative

weight

penalties:𝐽° = (𝑊 ° ) =

1

𝑠2
2
− 𝐾 ∑𝐾
𝑘=1 𝑙𝑜𝑔𝑝(𝑐𝑘 ; 𝑊𝑜:𝑐 ) + 𝛼 ∑𝑐=1 ∑𝑗=1 𝑤𝑜: 𝑐: 𝑗

Finally, the entire stacked NCAE classifier (SNCAE) is finetuned on the labeled
training data by the conventional error backpropagation through the network and
penalizing only the negative weights of the softmax layer. In our experiments, we trained
our network and tested it based on a leave-one-subject-out scenario 39 times (number of
data sets) until we reached the best average accuracy over the entirety of the testing process.
At this point, we considered s1 = 25, s2 = 5, s◦ = 2, α = 0.03, β = 3, and γ = 0.5 as the
optimum settings for giving the best accuracy. It is worth noting that more conventional
classification methods that deal directly with the voxel-wise ADCs of the entire kidney
volume as discriminative features encounter two difficulties: (i) varying input data size
requires either data truncation for larger kidney volumes or zero padding for smaller ones
and (ii) large data volumes lead to considerable time expenditures for training and
classification. Our SNCAE classifier exploits only the 100-component CDFs for the 3D
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ADC maps estimated at the b-values of (b10, b20, b30, b40, b50, b100, b200, and b300).
Fixing the input data size to 8 for such CDFs helps to overcome the above challenges for
arbitrary sizes of the original ADCs and notably accelerates the classification.
D. Experimental Results
The proposed CAD system has been tested on a 39 biopsy-proven cohort of which
8 are ATN and 31 are T-cell renal rejection transplants. The DW-MRI data of these patients
has been acquired at different b-values ranging from b0 to b1000 using a SIGNA Horizon
Scanner (General Electric Medical Systems), with the following parameters: TR = 8000
ms; FOV = 32 cm; in-plan resolution of 1.25 × 1.25 mm2; slice thickness = 4 mm; interslice gap = 0 mm; and two excitations. Since the segmentation is an essential step in
developing any CAD system for renal rejection types classification, we tested the
performance of our segmentation approach on the aforementioned DW-MRI data. Figure
16 shows some coronal segmentation results for one subject acquired at different b-values.
The accuracy of the proposed segmentation method has been evaluated using the
percentage Dice similarity coefficient (DSC%) [151], the 95-percentile modified
Hausdorff distance (MHD) [152], and the percentage of the absolute kidney volume
difference (AKVD%). Metrics were computed by comparing the ground truth
segmentation to results obtained by the developed segmentation technique. The ground
truth segmentations were manually created by an MR expert. The DSC%, MHD mm, and
AKVD% statistics obtained for all test data sets for our segmentation approach of the
kidney are 92.37±2.34%, 6.87±2.37 mm, and 14.1±4%, respectively, which confirms high
accuracy and robustness of the presented segmentation method, even at the higher b-values.
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For more details about the kidney segmentation evaluation metrics and kidney
segmentation results, see [138].

Figure 16. A sample coronal cross-sectional segmentation results of our segmentation
technique for one subject using DW-MRI data at b-values of (e.g., b0, b300, b500, b700,
and b900) s/mm2.
Following kidney segmentation, our CAD system classifies the rejection
transplants types. Figure 17 shows a sample of CDFs constructed for an ATN rejection
subject vs. a T-cell rejection one at b-values of (b50, b100, b200, and b300). Obviously,
the CDFs of the two different groups are completely separable; thus, those CDFs could be
used as discriminatory features for classification between the two kidney transplant
rejection groups. By using a SNCAE-based classifier and the previously constructed 8
CDFs along with a leave-one-subject-out classification scenario, our approach has
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correctly classified 98% of the data, namely, 8 out of 8 of ATN and 30 out of 31 of T-cell
rejection kidney transplants.

Figure 17. A sample of CDFs for two rejection subjects (ATN in solid lines and T-cell in
dashed lines) at b-values of (b50, b100, b200, and b300) s/mm2.
To validate our results, we compared the results obtained from the developed
SNCAE classifier with ten other well-known classi- fiers provided by the Weka tool [153]:
MultiClassClassifier (MCC), HyperPipes (HPs), IB1, K-nearest IBK, NNge, Logistic (Lg),
END, J48, RandomTree (RT), and RandomForest (RF). Table 4 compares our classifier to
these ten classifiers in terms of the number of ATN rejection subjects that have been
correctly classified (ATN/8), the number of T-cell rejection subjects that have been
correctly classi- fied (T-cell/31), and the total classification accuracy (Accuracy%). As
shown in Table 4, our classifier provides the best diagnostic accuracy of 98%, which
confirms the robustness and the accuracy of the developed classifier. These initial
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diagnostic results hold promise of the proposed CAD system as a reliable non-invasive
diagnostic tool.
Table 4
Diagnostic accuracy of our CAD system using SNCAE classifier and different classifiers
from Weka tool [150].

E. Conclusions
The CAD system presented here has been demonstrated to be capable of early
diagnosis and classification of renal transplant rejection types from 4D DW-MRI data. The
CAD system combines existing and new techniques for non-rigid image alignment, kidney
segmentation with a deformable boundary, estimation of spatial diffusion parameters
(ADCs), and an SNCAE classification of the rejection transplanted kidney status using
CDFs of the ADCs as integral status descriptions. In a test on a biopsy-proven cohort of 39
participants, our system showed an overall accuracy of 98% in detecting ATN and T-cell
rejection kidneys. These experimental results make the proposed framework a reliable noninvasive diagnostic tool for the early identification of renal rejection type. As a future
avenue, we intend to increase the test data-sets of both ATN and T-cell rejection kidney
transplant groups in order to further validate the accuracy and robustness of our framework
in both segmentation of the DW-MRI and diagnosis. In addition, we intend to account for
other different causes of rejection such as drug toxicity and viral infection, thus increasing
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the number of rejection groups to four, and then explore the ability of our framework to
distinguish between those four types of renal rejection.
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CHAPTER IV
CONCLUSION AND FUTURE WORK
This thesis focused on why it is important that an alternative to renal biopsies needs
to be developed that is non-invasive, less expensive economically, and saves time in
diagnosing. The computer aided diagnostic system is that alternative. The second part also
provide which parameters were the best for diagnosing. The third part of this thesis
demonstrated that not only can the CAD system diagnose between rejected and nonrejected but it shows a high level of accuracy in differentiating between ATN and T-cell
mediated rejection. With this thesis, it is clear to see that the CAD system using DW-MRI
will one day be an alternative in diagnosing renal graft dysfunction.
As already stated before some future steps that will be taken for this study will be
to obtain a larger more divers cohort of patients with are more verity of kidney disorder
(i.e. nephrotoxic mediated rejection, acute kidney disease, and pre-clinical rejection). It is
our goal as well to analyze smaller b-values and to confirm accuracy of both diagnosing
and differentiating different types of graft dysfunction.
However, though this thesis focused on diagnosing disorders of the kidney [154163], this work is not limited to diagnosing renal graft dysfunction. This work can be
extended to apply to analyzing and diagnosing disorders of the prostate [164-176], heart
[177-200], retina [201-207], lungs [208-249], and conditions of the brain such as Autism
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and Dyslexia [250-286].
In America prostate cancer is the second cancer-associated cause of deaths among
males. A study form 2015 found that there was about 220,800 new cases diagnosed that
year. The study also found that the mortality rate for prostate cancer was estimated to be at
27,540. Luckily, if prostate cancer is detected early it can increase the rate of survival since
doctors can provide better treatment at earlier stages of the disease. This fact has provided
incentive for researchers to develop non-invasive diagnostic CAD systems to detect
prostate cancer. Such works can be found in [164-176].
Another application CAD systems can be used for is assessing the heart. With CAD
systems the heart can be assessed for myocardial perfusion. CAD systems can also aid in
the diagnosis, prognosis, and management of ischemic heart disease in patients. Works on
this subject can be found [177-200].
Retinal abnormalities is another application that is implementing the use of CAD
systems. Many ophthalmologists utilize visual interpretation to identify diseases of the
retina. This however, can prove inaccurate and cause the patent to be missed diagnosed
and at times lead to fatality. Due to this fact, there is a great need for CAD systems in this
field of study. Works on this CAD systems in retinal abnormalities can be found [201-207].
Disorders of the lungs can also be have also been researched using CAD systems.
The main side effect of lung cancer treatment is lung injury caused by radiation therapy.
However, higher doses of radiation increase the effectiveness of controlling the size of the
cancer while at the same time injuring normal lung tissue. Almost 37% of patients who
undergo radiation will develop some form of lung injury. CAD systems can provide early
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detection of lung injury and improve management of radiation treatment. Studies in this
subject can be found [208-249].
Finally, CAD systems can one day be used in diagnosing conditions of the brain
such as Autism and Dyslexia. Autism is a neuro-development disorder with a multitude of
symptoms. The most dormant of the symptoms being that of repetitive behavior and social
impairments. Dyslexia on the other hand is a condition that causes the patient to not read,
right, or spell at an age-appropriate level despite maintain a normal to even high
intelligence in all other areas. By detecting these conditions early in life and schooling
children and parents can be provided with the necessary resources to live a somewhat
normal lifestyle with their disability. A CAD system that scans the brain can provide the
patent with early diagnosis and provide a better understanding in how these conditions
manifest in the brain. Such studies are included [250-286].
The field of medicine is ever changing and with these CAD systems we are
entering a new frontier that will improve the way doctors practice medicine and prolong
the life’s’ of patients.
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